Rodrigo T Calado

InstitutionUniversity of São Paulo
AddressSP
Brazil
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 83 publications over 20 distinct years, with a maximum of 8 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Slavov SN, Patané JSL, Bezerra RDS, Giovanetti M, Fonseca V, Martins AJ, Viala VL, Rodrigues ES, Santos EV, Barros CRS, Marqueze EC, Santos B, Aburjaile F, Neto RM, Moretti DB, Haddad R, Calado RT, Kitajima JP, Freitas E, Schlesinger D, Junior de Alcantara LC, Elias MC, Sampaio SC, Kashima S, Covas DT. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil. J Med Virol. 2021 12; 93(12):6782-6787. PMID: 34241897.
      Citations: 6   Article has an altmetric score of 4    Fields:    Translation:Humans
    2. Slavov SN, Giovanetti M, Dos Santos Bezerra R, Fonseca V, Santos EV, Rodrigues ES, Adelino T, Xavier J, Borges JS, Evaristo M, Lima MT, de Carvalho Pereira G, Yamamoto AY, Clé DV, Calado RT, Covas DT, Alcantara LCJ, Kashima S. Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil. Infect Genet Evol. 2021 09; 93:104976. PMID: 34174479.
      Citations: 1   Article has an altmetric score of 1    Fields:    Translation:Humans
    3. Garibaldi PMM, Oliveira LC, da Fonseca BA, Auxiliadora-Martins M, Miranda CH, Almado CEL, Langhi DM, Gilio RN, Palma LC, Gomes BBM, Bottura C, Barrientto LC, Donadel CD, Calado RT, De Santis GC. Histo-blood group A is a risk factor for severe COVID-19. Transfus Med. 2021 Jun 03. PMID: 34085363.
      Citations: 2   Fields:    
    4. Garibaldi PMM, Ferreira NN, Moraes GR, Moura JC, Espósito DLA, Volpe GJ, Calado RT, Fonseca BAL, Borges MC. Efficacy of COVID-19 outbreak management in a skilled nursing facility based on serial testing for early detection and control. Braz J Infect Dis. 2021 Mar-Apr; 25(2):101570. PMID: 33773990.
      Citations: 1   Article has an altmetric score of 4    Fields:    Translation:HumansPHPublic Health
    5. Mastellos DC, Skendros P, Calado RT, Risitano AM, Lambris JD. Efficacy matters: broadening complement inhibition in COVID-19. Lancet Rheumatol. 2021 Feb; 3(2):e95. PMID: 33521674.
      Citations: 4   Article has an altmetric score of 3    
    6. Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020 11; 220:108598. PMID: 32961333.
      Citations: 66   Article has an altmetric score of 141    Fields:    Translation:HumansCellsPHPublic Health